Aventis Lovenox Promotions Challenged By Coagulation Test Maker
Executive Summary
A diagnostics company that developed a coagulation test for use with Lovenox alleges Aventis is falsely promoting the antithrombotic as requiring "no routine monitoring" and being "therapeutic from dose one.